Approved in 2025
- Initial U.S. FDA approval year = 2025
- Metadata-derived regulatory filter
- Includes drugs first approved that year
- Later indications/formulations do not re-date drug
- Keep approval-year source independently verified
Class at a glance
- Initial U.S. FDA approval year = 2025
Practical pearls
- Includes drugs first approved that year
Other practical pearls
- Metadata-derived regulatory filter
Clinical role
- Later indications/formulations do not re-date drug
- Keep approval-year source independently verified
Self-check
- Which sodium-channel subtype does suzetrigine block?
Nav1.8. - Which neurokinin receptors does elinzanetant block?
NK1 and NK3.
Drugs in this class (4)
All drug classes · Open Approved in 2025 in the interactive console ↗